Gut microbiome alterations in Alzheimer’s disease
Explore this paper's citation graph
Summary
The gut microbiome of AD participants has decreased microbial diversity and is compositionally distinct from control age- and sex-matched individuals, which adds AD to the growing list of diseases associated with gut microbial alterations, as well as suggest that gut bacterial communities may be a target for therapeutic intervention.
- Type
- article
- Published
- 2017-10-19
- Cited by
- 1,870
- References
- 86
- Access
- Open access
- OpenAlex
- https://openalex.org/W2761210275
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:205612926
Keywords
Microbiome, Firmicutes, Biology, Bacteroidetes, Disease
References
- Inflammation induced by infection potentiates tau pathological features in transgenic mice.
- Corrigendum: Human rather than ape-like orbital morphology allows much greater lateral visual field expansion with eye abduction
- Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis
- Can a Bacterial Endotoxin be a Key Factor in the Kinetics of Amyloid Fibril Formation?
- Microbial Sources of Amyloid and Relevance to Amyloidogenesis and Alzheimer’s Disease (AD)
- Amyloid-β 42/40 Cerebrospinal Fluid Concentration Ratio in the Diagnostics of Alzheimer's Disease: Validation of Two Novel Assays
- Structure, Function and Diversity of the Healthy Human Microbiome
- Age-associated modifications of intestinal permeability and innate immunity in human small intestine.
- Risk of dementia: The Rotterdam Study
- Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD)
- Host–Bacterial Symbiosis in Health and Disease
- The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
- Circuits regulating pleasure and happiness: the evolution of reward-seeking and misery-fleeing behavioral mechanisms in vertebrates
- Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer’s disease
- Colonic bacterial composition in Parkinson's disease
- Gut microbiota are related to Parkinson's disease and clinical phenotype
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer’s Disease
- Obesity alters gut microbial ecology.
- Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease
- Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cited by
- Functional Characterization of the ycjQRS Gene Cluster from Escherichia coli: A Novel Pathway for the Transformation of d-Gulosides to d-Glucosides
- Gut-Bioreactor and Human Health in Future
- Gastrointestinal (GI) Tract Microbes and Microbial Neurotoxins in the Human Central Nervous System (CNS) in Alzheimer’s Disease (AD)
- Good Bug, Bad Bug: Breaking through Microbial Stereotypes.
- Arm im Darm
- Differences in Gut Microbiota Profiles between Autoimmune Pancreatitis and Chronic Pancreatitis.
- Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer’s Disease Brain: A Review
- Altered Bile Acid Profile in Mild Cognitive Impairment and Alzheimer’s Disease: Relationship to Neuroimaging and CSF Biomarkers
- Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?
- Towards an Integrative Understanding of tRNA Aminoacylation–Diet–Host–Gut Microbiome Interactions in Neurodegeneration
- Mind-altering with the gut: Modulation of the gut-brain axis with probiotics
- Of Microbes and Minds: A Narrative Review on the Second Brain Aging
- Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer’s Disease
- The Microbiome in Neurodegenerative Disease
- Bacteroidetes Neurotoxins and Inflammatory Neurodegeneration
- Vascular Cognitive Impairment and the Gut Microbiota
- Gut Microbiota is Altered in Patients with Alzheimer’s Disease
- Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases
- Nutritional Modulation of the Intestinal Microbiota; Future Opportunities for the Prevention and Treatment of Neuroimmune and Neuroinflammatory Disease
- Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Related papers
- GAMBARAN KOMPOSISI FILUM FIRMICUTES DAN BACTEROIDETES PADA OBESITAS (STUDI LITERATUR)
- RATIO OF MAIN PHYLOTYPES OF GUT MICROBIOTA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE BODY MASS INDEX.
- DIETARY FACTORS AFFECTING FIRMICUTES AND BACTEROIDETES RATIO IN SOLVING OBESITY PROBLEM: A LITERATURE REVIEW
- Development of a real‐time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs
- Bacteroidetes and Firmicutes levels in gut microbiota and effects of hosts TLR2/TLR4 gene expression levels in adult type 1 diabetes patients in Istanbul, Turkey.
- The association between body mass index and the oral Firmicutes and Bacteroidetes profiles of healthy individuals.
- The ratio of the main types of intestinal microbiota in patients with type 2 diabetes mellitus
- Effects of dietary fiber preparations made from maize starch on the growth and activity of selected bacteria from the Firmicutes, Bacteroidetes, and Actinobacteria phyla in fecal samples from obese children.
- Linkages of Firmicutes and Bacteroidetes populations to methanogenic process performance
- Age-related changes in the gut microbiota and the core gut microbiome of healthy Thai humans